Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Polyomavirus-associated nephropathy: Which Medications Are Safest? (18 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

18 medications are used for Polyomavirus-associated nephropathy, with 73 combined adverse event reports. The most reported drugs for Polyomavirus-associated nephropathy are LEFLUNOMIDE and HUMAN IMMUNOGLOBULIN G.

73
Total Reports
18
Drugs Used

All Medications for Polyomavirus-associated nephropathy Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
LEFLUNOMIDE Leflunomide 23 5,283 13,923 9.3%
HUMAN IMMUNOGLOBULIN G BIVIGAM 22 5,286 16,081 7.5%
CIDOFOVIR CIDOFOVIR 17 165 238 23.1%
PREDNISONE prednisone 11 22,555 57,772 14.2%
CIPROFLOXACIN Ciprofloxacin 9 2,671 13,894 6.1%
TACROLIMUS Tacrolimus 9 14,642 36,664 16.1%
EVEROLIMUS EVEROLIMUS 6 8,374 11,211 21.1%
IMMUNE GLOBULIN NOS - 5 428 1,046 19.0%
MYCOPHENOLATE MOFETIL Mycophenolate mofetil 5 13,776 25,831 18.4%

View all 18 drugs →

Most Reported Drugs for Polyomavirus-associated nephropathy

#1 most reported
#2 most reported
#3 most reported